Hypertension Flashcards

1
Q

Hypertension stages

A

Stage 1: CBP 140/90 + ABPM or HBPM > 135/85

Stage 2: CBP > 160/100 + ABPM or HBPM > 150/95

Stage 3/severe: > 180/120

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Accelerated/malignant HTN

A

Severe increase in BP to > 180/120 with signs of:
- retinal haemorrhage +/or papilloedema
- usually associated with TOD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

White coat HTN

A

15-30%

> 20/10mmHg discrepancy between clinic and ABPM or HBPM at diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Masked HTN

A

Clinic BP < 140/90 but BP higher on HBPM or ABPM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

RFs for HTN

A

1) Age
2) < 65y -men, 65-74y -women
3) African and black Caribbean
4) FH
5) Social deprivation
6) DM, CKD
7) Smoking, alcohol, salt, diet, obesity, lack of exercise
8) anxiety and stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Most common cause of secondary HTN

A

Renal disorders:
1) CKD - most common cause
2) Chronic pyelonephritis
3) DM nephropathy - proteinuria
4) Glomerulonephritis - haematuria
5) PCKD - mass, haematuria, FH
6) Obstructive uropathy -mass
7) Renal cell carcinoma - haematuria, loin pain, mass

Other causes:
1) Vascular:
- coarctation of the aorta
- renal artery stenosis

2) Endocrine:
- Primary hyperaldosteronism: most common curable cause of HTN
- phaeochromocytoma
- Cushing’s syndrome
- Acromegaly
- Hypothyroidism: increased diastolic BP
- Hyperthyroidism: increased systolic BP

3) Drugs:
- Alcohol: most common individual secondary cause of HTN
- ciclosporin
- cocaine, amphetamine, stimulants
- COCP / HRT
- steroids
- liquorice
- NSAIDs
- venlafaxine

4) Other conditions:
- pregnancy
- SLE, scleroderma, PAN
- OSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Coarctation of aorta findings

A

1) Difference in BP R & L arm

2) Absent/weak femoral pulses

3) R-F delay

40 suprasternal murmur radiating to back

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Renal artery stenosis findings

A

1) History of PVD

2) Abdominal bruit

3) BP resistant to treatment

4) Raised renin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Primary hyperaldosteronism

A

Most common curable cause of HTN

Adrenal adenoma

Presentation:
1) HypoK, raised bicarbonate (alkalosis), Na > 140 or larger than expected decrease in K when using thiazide diuretic

2) Tetany, muscle weakness, nocturia, polyuria

3) CCB can mask features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Phaemochromocytoma

A

Presentation:
1) Intermittently high or labile BP
2) Postural hypotension
3) Headaches
4) Sweating attacks, diaphoresis
5) Palpitations
6) Unexplained fever or abdominal pains
7) or asymptomatic

Can become malignant or have catastrophic haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Risks reduced for every 10mmhg reduction in BP

A

1) 17% reduction in CHD

2) 27% reduction in stroke

3) 28% reduction in heart failure

4) 13% reduction in all cause mortality

5% reduction in systolic BP reduces risk of major CVE by 10% even at normal BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Measuring clinic BP

A

If difference in BP > 15mmHg between both arms x 2, then measure BP on highest arm

Automated devices may give inaccurate measurement if pulse irregularity therefore always feel pulse first

If symptoms of postural hypotension and drop in 20mmHg on standing for 1 minute, then measure subsequent BPs standing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ABPM

A

2 measurements/hour during waking hours

Use average of at least 14 measurements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

HBPM

A

For each recording, 2 consecutive measurements at least 1 minute apart, twice daily.

4-7 days

Discard first day of measurements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

BP > 180/120

A

Same day specialist assessment:
- accelerated HTN (retinal haemorrhage/papilloedema)
- life-threatening symptoms: new onset confusion, chest pain, signs of HF or AKI

No symptoms:
- **urgent investigations for TOD **
- consider starting antihypertensive drug without waiting for ABPM/HBPM result
- if no TOD identified, repeat BP in 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Investigations for TOD

A

1) Urine dip: haematuria and Urine A:Cr

2) U&E, HbA1c, lipids

3) ECG

17
Q

Management stage 1 HTN

A

< 80y + ToD/QRisk > 10%, renal disease, DM, CVD:
- discuss starting antiHTN + lifestyle advice

Consider starting antiHTN if < 60y and QRisk < 10% or > 80y with CBP > 150/90

< 40y and no TOD - refer to secondary care to exclude secondary causes of HTN

18
Q

Management of stage 2 HTN

A

Offer antiHTN + lifestyle advice regardless of age

19
Q

AntiHTN if black African or Afro-Caribbean origin

A

CCB first line if no T2DM

Offer ARB over ACEI (increased risk of side effects)

20
Q

Management of HTN

A

Step 1:
1) ACEi/ARB if:
- < 55y and not black A/AC
- have T2DM of any age/race
- titrate every 4 weeks, check U&E 1-2 weeks after every dose increase

2) CCB if:
- > 55y and no T2DM
- black A/AC and no T2DM
- if CCB not tolerated off thiazide-like diuretic (indapamide)
- If HF - indapamide

Step 2:
1) A + C or D
2) C + A or D

Step 3:
1) A + C + D

Step 4: resistant HTN
- check for postural hypotension.
- confirm using ABPM/HBPM
1) K <=4.5 - low dose spironolactone - measure U&E within 1m
2) > 4.5 - a-blocker/BB

21
Q

HTN targets

A

1) Use CBP to monitor response to lifestyle or drugs

2) T2DM, symptoms of postural hypotension or > 80y - measure standing BP too and use standing BP if significant drop. If > 20 drop - review medications/advice

3) If white coat/masked HTN, then consider ABPM or HBPM in addition to CBP

4) Targets:
- < 80y - < 140/90 (HBPM < 135/85)
- > 80y - < 150/90 ( < 145/85)

22
Q

Annual review

A

1) Check BP:
- if raised, recheck 2-3x over next few weeks
- if suspect raised due to white-coat HTN, then for HBPM/ABPM

2) Can consider withdrawing if lifestyle changes, low BP, single drug
- wean
- review 4 weekly for 6 months then 2-3x/year to check for recurrence

3) U&E + urine ACR :
- if eGFR < 60 or ACR > 3mg/mmol - CKD

4) Lipids and QRisk

23
Q

ACEi / ARB

A

MOA:
1) reduce AI –> AII –> reduced aldosterone secretion –> reduced Na + H20 retention
2) AII constricts efferent arterioles - reduced constriction reduces pressure on glomerular capillaries - renoprotective

CI:
- angio-oedema
- If on aliskerin + DM/CKD
- pregnancy & breastfeeding
- renovascular disease

Caution:
- HOCM
- PVD - risk of silent renovascular disease
**- severe HF/AS **
- furosemide > 80mg/day -increases hypotension

SE:
- HyperK
- Cough
- Angio-oedema (also avoid ARBs)
- arrhythmia, sleep, taste

Interactions:
- NSAIDs - increased risk of renal impairment and hypotension
- Antacid - reduced absorption
- Heparin - HyperK
- Spironolactione - HyperK, use lowest dose of both drugs
-Lithium -toxicity, monitor levels

Monitoring
- U&E before and at 1-2 weeks, then annually

24
Q

Abnormal test results - ACEi

A

eGFR reduces by < 25% or creatinine by < 30% - continue, recheck in 1-2 weeks

eGFR reduces by >=25% or Cr increases by >=30%:
- ?volume depletion
- Reduce/stop NSAIDs, CCB, nitrates, K supplements, diuretics
- if persists - stop ACEI or reduce to lower dose and recheck in 5-7 days

K >= 5:
- Stop of reduce K-sparing diuretics, nephrotoxic drugs ( NSAID)

K 5-5.9 despite above changes - reduce ACEi and re-check in 5-7 days

K >= 6 despite measures - stop

Or K >=5.5 - stop

25
Q

Thiazide-like diuretics

A

Avoid in:
- HypoNa/HypoK/HyperCa
- Addison’s
- eGFR < 30
- pregnancy - neonatal thrombocytopenia, BM suppression, jaundice, electrolyte disturbance, reduced placental perfusion

Caution in:
- DM, gout, SLE - exacerbate these
- CVD + glucosides - risk of hypoK

Monitoring:
- U&E and LFT before
- U&E - Na and K during first week

26
Q

CCB

A

CCB, except amlodipine, should be avoided in heart failure

Angina, if BB contraindicated, may prefer rate-limiting CCB

27
Q

Spironolactone

A

Step 4 + K <=4.5

Dose 225mg OD

Monitor U&E within 1 month

CI:
- Addison’s
- AKI
- HyperK

SE:
- AKI
- agranulocytosis, leucopenia, thrombocytopenia
- alopecia
- benign breast tumour/pain/gynaecomastia
- libido change
- hyperK (stop), hypoNa
- leg cramps
- pruritis
- SJS

Interactions:
- ACEI - lowest doses of both
- digoxin
-lithium

28
Q

B-blockers

A

HTN + HF: bisoprolol, carvedilol, nebivolol

HTN + angina: atenolol, bisoprolol, metoprolol

HTN + previous MI (no HF) : metoprolol, propranolol, timolol, atenolol

29
Q

Alpha-blockers

A

Doxazosin or Terazosin

CI:
- postural hypotension
- micturition syncope - BPH
- do not use MR if GI obstruction as outer membrane not digested
- caution in HF
- pregnant/breast feeding

Risk of intraoperative Floppy Iris Syndrome during cataract surgery

Doxazosin SR - titrate 1mg/day, double dose after 1-2 weeks up to max 16mg/day (usually 4mg)

30
Q

Which combination of antiHTN should be avoided in DM?

A

BB + thiazide like diuretic

31
Q

At what point do thiazide diuretics become ineffective in CKD?

A

eGFR < 30 - avoid as not effective

32
Q

Why has use of BBs declined sharply in past 5 years to treat HTN?

A

Less likely to prevent stroke and potential impairment of glucose tolerance